Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study

Background: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. Aim: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. Materials and Methods: A cross-sectional study was carried out for a period...

Full description

Bibliographic Details
Main Authors: Satya Bhgath Gorityala, Uday Venkat Mateti, Venkateswarlu Konuru, Srinivas Martha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2015;volume=7;issue=3;spage=226;epage=229;aulast=Gorityala
_version_ 1818022497380990976
author Satya Bhgath Gorityala
Uday Venkat Mateti
Venkateswarlu Konuru
Srinivas Martha
author_facet Satya Bhgath Gorityala
Uday Venkat Mateti
Venkateswarlu Konuru
Srinivas Martha
author_sort Satya Bhgath Gorityala
collection DOAJ
description Background: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. Aim: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. Materials and Methods: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch′s and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. Results: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient′s early continuation (3-4 months) treatment, and 47.66% of the patient′s only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. Conclusion: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended.
first_indexed 2024-12-10T03:29:22Z
format Article
id doaj.art-b0ceb7b7cfe044adab0d6968a0429e83
institution Directory Open Access Journal
issn 0975-7406
0976-4879
language English
last_indexed 2024-12-10T03:29:22Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj.art-b0ceb7b7cfe044adab0d6968a0429e832022-12-22T02:03:52ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74060976-48792015-01-017322622910.4103/0975-7406.160034Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional studySatya Bhgath GorityalaUday Venkat MatetiVenkateswarlu KonuruSrinivas MarthaBackground: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. Aim: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. Materials and Methods: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch′s and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. Results: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient′s early continuation (3-4 months) treatment, and 47.66% of the patient′s only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. Conclusion: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2015;volume=7;issue=3;spage=226;epage=229;aulast=GorityalaCross-sectionalKochtreatment interruptiontuberculosis
spellingShingle Satya Bhgath Gorityala
Uday Venkat Mateti
Venkateswarlu Konuru
Srinivas Martha
Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
Journal of Pharmacy and Bioallied Sciences
Cross-sectional
Koch
treatment interruption
tuberculosis
title Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_full Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_fullStr Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_full_unstemmed Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_short Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_sort assessment of treatment interruption among pulmonary tuberculosis patients a cross sectional study
topic Cross-sectional
Koch
treatment interruption
tuberculosis
url http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2015;volume=7;issue=3;spage=226;epage=229;aulast=Gorityala
work_keys_str_mv AT satyabhgathgorityala assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT udayvenkatmateti assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT venkateswarlukonuru assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT srinivasmartha assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy